LivaNova rises following possible CMS reimbursement boost
LivaNova (NASDAQ:LIVN) is up ~3% in Wednesday afternoon trading as it is seen as a beneficiary of a CMS advisory meeting in which members discussed raising the reimbursement rate for vagus nerve stimulation by ~40%.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.